# A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

> **NCT07196722** · PHASE2,PHASE3 · RECRUITING · sponsor: **Janssen Research & Development, LLC** · enrollment: 1092 (estimated)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** Icotrokinra
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07196722
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-03
- **Primary completion:** 2028-09-19
- **Final completion:** 2032-10-06
- **Target enrollment:** 1092 (ESTIMATED)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07196722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07196722, "A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT07196722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*